Literature DB >> 30112582

Updates on Diabetic Foot and Charcot Osteopathic Arthropathy.

Brian M Schmidt1, Crystal M Holmes2.   

Abstract

PURPOSE OF REVIEW: Diabetes mellitus affects approximately 30.8 million people currently living in the USA. Chronic diabetes complications, including diabetic foot complications, remain prevalent and challenging to treat. We review clinical diagnosis and challenges providers may encounter when managing diabetic foot ulcers and Charcot neuroarthropathy. RECENT
FINDINGS: Mechanisms controlling these diseases are being elucidated and not fully understood. Offloading is paramount to heal and manage diabetic foot ulcers and Charcot neuroarthropathy. Diabetic foot ulcers recur and the importance of routine surveillance and multidisciplinary approach is essential. Several predictors of failure in Charcot foot include a related diabetic foot ulcer, midfoot or rearfoot location of the Charcot event, and progressive bony changes on interval radiographs. Patients with diabetic foot ulcer and/or Charcot neuroarthropathy are in need of consistent and regular special multidisciplinary care. If not diagnosed early and managed effectively, morbidity and mortality significantly increase.

Entities:  

Keywords:  Charcot osteopathic arthropathy; Diabetic foot; Infection; Limb salvage; Neuropathic ulcers; Podiatry

Mesh:

Year:  2018        PMID: 30112582     DOI: 10.1007/s11892-018-1047-8

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN: 1534-4827            Impact factor:   4.810


  105 in total

Review 1.  Wound dressings.

Authors:  Vanessa Jones; Joseph E Grey; Keith G Harding
Journal:  BMJ       Date:  2006-04-01

2.  Long-term follow-up in diabetic Charcot feet with spontaneous onset.

Authors:  J Fabrin; K Larsen; P E Holstein
Journal:  Diabetes Care       Date:  2000-06       Impact factor: 19.112

3.  The consequences of complacency: managing the effects of unrecognized Charcot feet.

Authors:  D K Wukich; W Sung; S A M Wipf; D G Armstrong
Journal:  Diabet Med       Date:  2011-02       Impact factor: 4.359

4.  Clostridial Collagenase for the Management of Diabetic Foot Ulcers: Results of Four Randomized Controlled Trials.

Authors:  John C Lantis Ii; Ian Gordon
Journal:  Wounds       Date:  2017-08-25       Impact factor: 1.546

5.  Nitric oxide enhances osteoclastogenesis possibly by mediating cell fusion.

Authors:  Dorrin Nilforoushan; Azza Gramoun; Michael Glogauer; Morris F Manolson
Journal:  Nitric Oxide       Date:  2009-04-21       Impact factor: 4.427

6.  The RANKL/RANK/OPG signaling pathway mediates medial arterial calcification in diabetic Charcot neuroarthropathy.

Authors:  Agbor Ndip; Alfred Williams; Edward B Jude; Ferdinand Serracino-Inglott; Steve Richardson; J V Smyth; Andrew J M Boulton; M Yvonne Alexander
Journal:  Diabetes       Date:  2011-06-09       Impact factor: 9.461

7.  The effect of zoledronic acid on the clinical resolution of Charcot neuroarthropathy: a pilot randomized controlled trial.

Authors:  Toni-Karri Pakarinen; Heikki-Jussi Laine; Heikki Mäenpää; Pentti Mattila; Jorma Lahtela
Journal:  Diabetes Care       Date:  2011-05-18       Impact factor: 19.112

8.  Physician knowledge of a rare foot condition - influence of diabetic patient population on self-described knowledge and treatment.

Authors:  Brian M Schmidt; James S Wrobel; Crystal M Holmes
Journal:  Clin Diabetes Endocrinol       Date:  2017-02-08

9.  Matrix metalloproteinases and diabetic foot ulcers: the ratio of MMP-1 to TIMP-1 is a predictor of wound healing.

Authors:  M Muller; C Trocme; B Lardy; F Morel; S Halimi; P Y Benhamou
Journal:  Diabet Med       Date:  2008-04       Impact factor: 4.359

10.  Developing an evidence-based clinical pathway for the assessment, diagnosis and management of acute Charcot Neuro-Arthropathy: a systematic review.

Authors:  Tamara E Milne; Joseph R Rogers; Ewan M Kinnear; Helen V Martin; Peter A Lazzarini; Thomas R Quinton; Frances M Boyle
Journal:  J Foot Ankle Res       Date:  2013-07-30       Impact factor: 2.303

View more
  5 in total

1.  Case series on the Charcot neuroarthropathy in hands after cervical central cord syndrome.

Authors:  Wenting Wang; Anni Tong; Nan Liu; Fin Biering-Soerensen; Shuai Tong
Journal:  BMC Musculoskelet Disord       Date:  2022-06-06       Impact factor: 2.562

Review 2.  Factors impacting the evidence-based assessment, diagnosis and management of Acute Charcot Neuroarthropathy: a systematic review.

Authors:  D Diacogiorgis; B M Perrin; M I C Kingsley
Journal:  J Foot Ankle Res       Date:  2021-04-07       Impact factor: 2.303

3.  Ocular Manifestations and Neuropathy in Type 2 Diabetes Patients With Charcot Arthropathy.

Authors:  Marilia Trindade; Jessica Castro de Vasconcelos; Gabriel Ayub; Alex Treiger Grupenmacher; Delma Regina Gomes Huarachi; Marina Viturino; Maria Lucia Correa-Giannella; Yeelen Ballesteros Atala; Denise Engelbrecht Zantut-Wittmann; Maria Candida Parisi; Monica Alves
Journal:  Front Endocrinol (Lausanne)       Date:  2021-04-21       Impact factor: 5.555

4.  A fully automatic system to assess foot collapse on lateral weight-bearing foot radiographs: A pilot study.

Authors:  J Lauder; J Harris; B Layton; P Heire; A Sorani; M DeSancha; A K Davison; C Sammut-Powell; C Lindner
Journal:  Comput Methods Programs Biomed       Date:  2021-10-30       Impact factor: 5.428

Review 5.  Prevention and Management Strategies for Diabetic Neuropathy.

Authors:  Sasha Smith; Pasha Normahani; Tristan Lane; David Hohenschurz-Schmidt; Nick Oliver; Alun Huw Davies
Journal:  Life (Basel)       Date:  2022-08-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.